Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Mar 7, 2007

Five Indications Added to Lipitor Label

  • Pfizer’s anticholesterol drug, Lipitor, widely prescribed to reduce cardiovascular events in patients without heart disease, can now be used to treat at risk patients with established heart disease, according to the company.

    The FDA added five new indications to Lipitor. "These new indications are important since many patients who have heart disease remain at risk for another cardiovascular event, and now these indications broaden the means to reduce their risk," comments Dr. John C. LaRosa, president and professor of medicine at the State University of New York Downstate Medical Center in Brooklyn and Pfizer consultant.

    Lipitor is now approved to reduce the risk of nonfatal heart attacks, fatal and nonfatal strokes, certain types of heart surgery, hospitalization for heart failure, and chest pain in patients with heart disease.



Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »